Search
for
Sort by
Research 331–360 of 1000+
- May patients receiving 5-alpha-reductase inhibitors be in higher risk of COVID-19 complications?
- Association of androgenetic alopecia with a more severe form of COVID-19 infection
- Side Effects of COVID-19 Vaccination Among Medical Students in Bangladesh: A Cross-Sectional Study
- Gender Differences in Response to COVID-19 Infection and Vaccination
- Androgen sensitivity gateway to COVID‐19 disease severity
- Risk factors associated with development and persistence of long COVID
- Upper gastrointestinal bleeding during the COVID-19 pandemic; particularities of diagnosis and therapy
- Clinical Evaluation of COVID-19 Survivors at a Public Multidisciplinary Health Clinic
- Beau’s Lines and COVID-19; A Systematic Review on Their Association
- Rare and common manifestations of COVID‐19 in children
- What’s Sex Got to Do With COVID-19? Gender-Based Differences in the Host Immune Response to Coronaviruses
- Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients
- Autoimmune Skin Diseases in the Era of COVID-19: Pathophysiological Insights and Clinical Implications
- Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial – Biochemical)
- Do Anti-androgens Have Potential as Therapeutics for COVID-19?
- - Hair steroid concentration before and after the beginning of the COVID-19 pandemic in preschoolers: the moderating effect of family characteristics
- Can the golden nutraceutical frankincense combat COVID‐19?
- Referee report. For: Practices, awareness, and perception towards home-based COVID-19 management among the general population in Mangalore city in south India [version 2; peer review: 1 approved, 1 approved with reservations]
- Steroid 5α-reductase 2 deficiency leads to reduced dominance-related and impulse-control behaviors
- Protective trend of anti-androgen therapy during the COVID-19 pandemic: A meta-analysis
- Dermatology practice in a high-tech world
- The role of sleep in telogen effluvium and trichodynia: A commentary in the context of the current pandemic
- Drug interactions between common dermatological medications and the oral anti-COVID-19 agents nirmatrelvir-ritonavir and molnupiravir
- The Impact of Immune-Modifying Treatments for Skin Diseases on the Immune Response to COVID-19 Vaccines: a Narrative Review
- Induced pluripotent stem cells: Generation methods and a new perspective in COVID-19 research
- Role of testosterone in SARS-CoV-2 infection: A key pathogenic factor and a biomarker for severe pneumonia
- Persistence of Long-COVID symptoms in a heterogenous prospective cohort
- Long COVID: Clinical characteristics, proposed pathogenesis and potential therapeutic targets
- PATHOGENETIC FEATURES OF THE INFLUENCE OF A PAST CORONAVIRUS INFECTION IN WOMEN WITH POLYCYSTIC OVARIAN SYNDROME
- Targeting host cell proteases as a potential treatment strategy to limit the spread of SARS‐CoV‐2 in the respiratory tract